Acute Myeloid Leukemia (AML): Crenolanib Versus Midostaurin in Newly Diagnosed Subjects
With FLT3 Mutated AML
Does the drug Crenolanib help patients with acute myeloid leukemia survive?
Basic Study Information
Purpose:Study Reference #: ILEU17106
This purpose of this study is to compare the efficacy of crenolanib with midostaurin
administered following induction chemotherapy and consolidation therapy on event-free
survival in newly diagnosed acute myeloid leukemia subjects with FLT3 mutation.
Lead Researcher (Principal Investigator)
Lead Researcher: Jane Liesveld, MD
Study Contact InformationStudy Coordinator: Haley Misch
Phone: (585) 275-9485
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search